Early palliative care reduces hospital readmissions by 23% for patients with cancer
the ONA take:
According to a new study presented at the American Society of Clinical Oncology (ASCO) Palliative Care in Oncology Symposium in Boston, Massachusetts, researchers at Duke University Hospital in Durham, North Carolina, have designed a collaborative approach in cancer care that decreased the number of patients readmitted to the hospital or sent to intensive care.
Their new treatment model consists of medical oncologists and physicians specializing in palliative care rounding together to care for patients with solid tumors. The two types of physicians met multiple times a day to review their patients' care.
Then, the researchers reviewed the 2,353 inpatient encounters that the cooperative team rounded on since 2011. Their analysis showed that there was a 23% reduction in the number of patients readmitted within 1 week of discharge. They also found a 15% reduction in the number of patients transferred to intensive care. The collaborative team model also allowed patients to be discharged approximately 8 hours sooner and hospice referrals rose 17%.
The findings suggest that implementing palliative care sooner in patient care, rather than prolonging palliative care until disease progression, will allow patients to talk about their desired quality of life earlier. The researchers hope to also conduct cost-benefit analyses.
Researchers designed a collaborative approach that decreased the number of patients readmitted.
Doctors at Duke University Hospital have developed a new collaborative model in cancer care that reduced the rates at which patients were sent to intensive care or readmitted to the hospital after discharge. The Duke researchers shared their findings today at the Palliative Care in Oncology Symposium sponsored by the American Society of Clinical Oncology.
In the new treatment model, medical oncologists and palliative care physicians partnered in a "co-rounding" format to deliver cancer care for patients admitted to Duke University Hospital's solid tumor unit. The Duke model fostered collaboration and communication between the specialists, who met several times a day to discuss patient care.
Sign Up for Free e-newsletters
- Scalp Cooling With Dignicap May Reduce Alopecia During Chemotherapy for Breast Cancer
- Evolution of HER2-Positive Breast Cancer: Yesterday, Today, and Tomorrow
- Dedicated End-of-Life Education Program Improves Nurses' Care, Patient and Family Satisfaction
- Reflexology, Aromatherapy May Reduce Pain, Anxiety of Brachytherapy for Cervical Cancer
- Accurate Understanding of Capacity May Improve Workflow, Efficiency in Infusion Suite
- Multimodal Follow-up Improved Postradiotherapy Sexual Health in Lower GI, Gynecologic Cancers
- Lung Cancer Screening Program In Ambulatory Clinics May Improve Detection Rates
- Nursing Practice Change Improved Chemo Administration, But Old Habits Die Hard
- Simple Adjustment Key to Paclitaxel Infusion Protocol That Reduced Hypersensitivity Reactions
- Online Program Aims to Assist With Clinical Trial Enrollment for Hematologic Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|